Literature DB >> 24482741

Mouse induced pluripotent stem cell microenvironment generates epithelial-mesenchymal transition in mouse Lewis lung cancer cells.

Ling Chen1, Akifumi Mizutani2, Tomonari Kasai2, Ting Yan2, Guoliang Jin2, Arun Vaidyanath2, Bishoy Ya El-Aarag3, Yixin Liu4, Takayuki Kudoh2, David S Salomon5, Li Fu6, Masaharu Seno2.   

Abstract

Induced pluripotent stem (iPS) cells may be a powerful tool in regenerative medicine, but their potential tumorigenicity is a significant challenge for the clinical use of iPS cells. Previously, we succeeded in converting miPS cells into cancer stem cells (CSCs) under the conditions of tumor microenvironment. Both stem cells and tumor cells are profoundly influenced by bi-directional communication with their respective microenvironment, which dictates cell fate determination and behavior. The microenvironment derived from iPS cells has not been well studied. In this paper, we have investigated the effects of secreted factors from Nanog-mouse iPS (miPS) cells on mouse Lewis lung cancer (LLC) cells that are found in the conditioned media. The results demonstrated that miPS cells secrete factors that can convert the epithelia phenotype of LLC cells to a mesenchymal phenotype, and that can promote tumorigenisity, migration and invasion. Furthermore, LLC cells that have been exposed to miPS conditioned medium became resistant to apoptosis. These various biological effects suggest that the miPS microenvironment contain factors that can promote an epithelial-mesenchymal transition (EMT) through an active Snail-MMP axis or by suppressing differentiation in LLC cells.

Entities:  

Keywords:  Mouse induced pluripotent stem cell; epithelial-mesenchymal transition; lung Lewis cancer cell; stem cell microenvironment

Year:  2014        PMID: 24482741      PMCID: PMC3902235     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  29 in total

Review 1.  EMT: when epithelial cells decide to become mesenchymal-like cells.

Authors:  Raghu Kalluri
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

Review 2.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

Review 3.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

4.  Identification of a cancer stem-like population in the Lewis lung cancer cell line.

Authors:  An-Mei Zhang; Ye Fan; Quan Yao; Hu Ma; Sheng Lin; Cong-Hui Zhu; Xin-Xin Wang; Jia Liu; Bo Zhu; Jian-Guo Sun; Zheng-Tang Chen
Journal:  Asian Pac J Cancer Prev       Date:  2012

5.  The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts.

Authors:  Maty Tzukerman; Tzur Rosenberg; Irena Reiter; Shoshana Ben-Eliezer; Galit Denkberg; Raymond Coleman; Yoram Reiter; Karl Skorecki
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

6.  Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias.

Authors:  Maaike Hoekstra; Christine L Mummery; Arthur A M Wilde; Connie R Bezzina; Arie O Verkerk
Journal:  Front Physiol       Date:  2012-08-31       Impact factor: 4.566

7.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

Authors:  Adriana Sánchez-Danés; Yvonne Richaud-Patin; Iria Carballo-Carbajal; Senda Jiménez-Delgado; Carles Caig; Sergio Mora; Claudia Di Guglielmo; Mario Ezquerra; Bindiben Patel; Albert Giralt; Josep M Canals; Maurizio Memo; Jordi Alberch; José López-Barneo; Miquel Vila; Ana Maria Cuervo; Eduard Tolosa; Antonella Consiglio; Angel Raya
Journal:  EMBO Mol Med       Date:  2012-03-08       Impact factor: 12.137

8.  Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.

Authors:  Chun-Yu Lin; Pei-Hsun Tsai; Chithan C Kandaswami; Geen-Dong Chang; Chia-Hsiung Cheng; Chang-Jen Huang; Ping-Ping Lee; Jiuan-Jiuan Hwang; Ming-Ting Lee
Journal:  Mol Cancer       Date:  2011-07-21       Impact factor: 27.401

Review 9.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  7 in total

1.  Some Ethical Concerns About Human Induced Pluripotent Stem Cells.

Authors:  Yue Liang Zheng
Journal:  Sci Eng Ethics       Date:  2015-08-15       Impact factor: 3.525

2.  Oxygen Tension Regulates Human Mesenchymal Stem Cell Paracrine Functions.

Authors:  Joseph Paquet; Mickael Deschepper; Adrien Moya; Delphine Logeart-Avramoglou; Catherine Boisson-Vidal; Hervé Petite
Journal:  Stem Cells Transl Med       Date:  2015-05-15       Impact factor: 6.940

3.  Wnt/β-Catenin and MEK-ERK Signaling are Required for Fibroblast-Derived Extracellular Matrix-Mediated Endoderm Differentiation of Embryonic Stem Cells.

Authors:  Kevin Dzobo; Matjaz Vogelsang; M Iqbal Parker
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

Review 4.  The role of adipose-derived stem cells in breast cancer progression and metastasis.

Authors:  Riccardo Schweizer; Wakako Tsuji; Vijay S Gorantla; Kacey G Marra; J Peter Rubin; Jan A Plock
Journal:  Stem Cells Int       Date:  2015-04-27       Impact factor: 5.443

5.  A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells.

Authors:  Sergey Malchenko; Simone Treiger Sredni; Hitoshi Hashimoto; Atsushi Kasai; Kazuki Nagayasu; Jianping Xie; Naira V Margaryan; Kaoru Seiriki; Rishi R Lulla; Richard E B Seftor; Lauren M Pachman; Herbert Y Meltzer; Mary J C Hendrix; Marcelo B Soares
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

Review 6.  Cancer stem cells converted from pluripotent stem cells and the cancerous niche.

Authors:  T Kasai; L Chen; Az Mizutani; T Kudoh; H Murakami; L Fu; M Seno
Journal:  J Stem Cells Regen Med       Date:  2014-04-30

7.  Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.

Authors:  Md Jahangir Alam; Ryota Takahashi; Said M Afify; Aung Ko Ko Oo; Kazuki Kumon; Hend M Nawara; Aprilliana Cahya Khayrani; Juan Du; Maram H Zahra; Akimasa Seno; David S Salomon; Masaharu Seno
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.